José van den Berg
- Algorithms
- Billing code
- Biomarker
- Cancer of Unknown Primary
- cfDNA
- DNA
- Education
- End of Treatment
- GENAYA project
- Hartwig Medical Database
- Hartwig Medical Foundation
- Innovation
- IT
- Lab process
- Learning healthcare system
- Molecular diagnostics
- OncoAct
- oncoanalyser
- Participating hospitals
- Patients' stories
- Personalized treatment
- Quality
- Rare cancers
- Re-use data
- Research
- Scientific publications
- Treatment
- Uncategorized
- Whole genome sequencing
- Working in the cloud
José van den Berg
By using WGS, we took a step forward in molecular diagnostics in our department from the analysis of less than …
Karin Govaert
The fact that the CPCT, together with Hartwig Medical Foundation, has managed to bundle data, knowledge and expertise from almost …
Kim Monkhorst
We want to extract the maximum amount of information from the patient’s tumor. This DNA test is the The complete …
Gerrit Meijer
We are proud that we succeeded in implementing the complete DNA test in standard of care diagnostics, together with Hartwig …
Anne van Herwijnen
I know how important knowledge of hereditary predisposition to cancer can be. This is why I think it is so …
Peter Holleman
The complete DNA test allows for personalized treatment and so limits the chance of undesirable side effects.
Veronica van Nederveen
The complete DNA test provides a complete overview of all potential targeted cancer treatments. The patient and the attending physician …
Pieter Hoekstra
The complete DNA test is an important step toward treating forms of cancer that currently cannot be treated with targeted …
Carla van Herpen
It is important to unravel the DNA in rare types of cancer; 21% of patients with cancer have a rare …
Emile Voest
More and more cancer drugs are only suitable for a small group of patients. However, we are often not capable …
The knowledge we gather with WGS can bring us a step closer to our goal to find an effective and suitable treatment for every single patient, not based on ‘one size fits all’, but adjusted to the characteristics of the patient and the tumor.